Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Efficacy of ustekinumab vs. advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis.

Welty M, Mesana L, Padhiar A, Naessens D, Diels J, van Sanden S, Pacou M.

Curr Med Res Opin. 2020 Jan 29:1-12. doi: 10.1080/03007995.2020.1716701. [Epub ahead of print]

PMID:
31960724
2.

Reslizumab Compared with Benralizumab in Patients with Eosinophilic Asthma: A Systematic Literature Review and Network Meta-Analysis.

Casale TB, Pacou M, Mesana L, Farge G, Sun SX, Castro M.

J Allergy Clin Immunol Pract. 2019 Jan;7(1):122-130.e1. doi: 10.1016/j.jaip.2018.08.036. Epub 2018 Sep 11.

PMID:
30217529
3.

Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France.

Limosin F, Belhadi D, Comet D, Pacou M, Bouju S, Van Impe K, Guillon P.

J Clin Psychopharmacol. 2018 Feb;38(1):19-26. doi: 10.1097/JCP.0000000000000827.

4.
5.

Patient and physician preferences for the treatment of chronic hepatitis C virus infections: does the perspective matter?

Pacou M, Basso F, Gore C, Hass B, Taieb V, Cognet M, Pol S.

Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1063-8. doi: 10.1097/MEG.0000000000000410.

PMID:
26049711
6.

A network meta-analysis to compare simeprevir with boceprevir and telaprevir in combination with peginterferon-α and ribavirin in patients infected with genotype 1 Hepatitis C virus.

Taieb V, Pacou M, Ho S, Pettré S, Van Sanden S, Pisini M, Ustianowski A, Mehnert A.

J Med Econ. 2015;18(10):787-96. doi: 10.3111/13696998.2015.1046880. Epub 2015 May 26. Review.

PMID:
25934147
7.

Mixed Treatment Comparisons to Compare Simeprevir with Boceprevir and Telaprevir in Combination with Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected with Genotype 1 Hepatitis C Virus (Hcv).

Taieb V, Pacou M, Van Sanden S, Sbarigia U, Mehnert A, Duchesne I.

Value Health. 2014 Nov;17(7):A665. doi: 10.1016/j.jval.2014.08.2450. Epub 2014 Oct 26. No abstract available.

8.

French Utility Elicitation in Previously Treated European Patients with Indolent Non-Hodgkin Lymphoma (INHL).

Bec M, Cognet M, Taieb V, Pacou M, Gauthier A.

Value Health. 2014 Nov;17(7):A646. doi: 10.1016/j.jval.2014.08.2340. Epub 2014 Oct 26. No abstract available.

9.

Proposed Checklist for Non-Statisticians To Assess the Quality of A Network Meta-Analysis in the Context of A Nice Submission.

Pacou M, Gauthier A, Taieb V, Bec M, Belhadi D, Guillemot J.

Value Health. 2014 Nov;17(7):A579-80. doi: 10.1016/j.jval.2014.08.1960. Epub 2014 Oct 26. No abstract available.

10.

Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK.

Breuer J, Pacou M, Gautier A, Brown MM.

Neurology. 2014 Jul 8;83(2):e27-33. doi: 10.1212/WNL.0000000000000584.

PMID:
25002574
11.

Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK.

Breuer J, Pacou M, Gauthier A, Brown MM.

Neurology. 2014 Jan 21;82(3):206-12. doi: 10.1212/WNL.0000000000000038. Epub 2014 Jan 2. Erratum in: Neurology. 2014 Jun 17; 82(24): 2256..

Supplemental Content

Support Center